Aug 30, 2026 07:45AM
Aug 20, 2026 08:00AM
Jul 28, 2026 08:00AM
Jul 2, 2026 08:00AM
Jun 15, 2026 02:30AM
Jun 15, 2026 02:30AM
Jun 5, 2026 06:40AM Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disea
Jun 2, 2026 08:00AM
May 21, 2026 08:00AM
May 21, 2026 08:00AM
May 21, 2026 02:30AM
May 21, 2026 02:30AM
May 19, 2026 02:30AM
May 19, 2026 02:30AM Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
May 18, 2026 08:41AM
May 18, 2026 08:41AM
May 7, 2026 02:30AM
Mar 26, 2026 09:55AM
Mar 16, 2026 03:30AM
Mar 4, 2026 08:00AM
Mar 4, 2026 08:00AM New FDA 510(k) Clearance Expands Bayer’s MEDRAD® MRXperion MR Injection System Support Across Diverse Range of MR Environments
Feb 23, 2026 10:28AM
Feb 5, 2026 12:15PM
Feb 5, 2026 12:15PM
Jan 29, 2026 08:30AM
Jan 13, 2026 02:15PM
Jan 13, 2026 09:00AM
Jan 12, 2026 08:00AM Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus
Dec 4, 2025 02:30AM
Dec 2, 2025 08:05AM
Dec 1, 2025 11:30AM
Nov 23, 2025 11:28AM
Nov 20, 2025 08:00AM
Nov 20, 2025 08:00AM
Nov 6, 2025 09:00AM  KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease
Oct 24, 2025 01:25PM
Oct 24, 2025 01:25PM
Oct 7, 2025 08:21AM
Oct 7, 2025 02:00AM
Sep 25, 2025 08:00AM
Sep 22, 2025 06:00AM
Aug 27, 2025 07:50AM Gadoquatrane New Drug Application Accepted for Review by U.S. FDA

330,186 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All